glp-1 pediatric obesity receptor agonists in and diabetes: a systematic review of efficacy, metabolic effects, and safety Advancements in FDA approvals for

References: Forman HJ, Zhang H, Rinna A

The FDAs Pharmacy Compounding Advisory Committee (PCAC) will review seven peptides to potentially allow compounders to produce them

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): 53

Gip se kht l chn lng, lm gim tnh trng mn trng c

Erythrodermic psoriasis is a rare but severe variant involving widespread erythema and desquamation over most of the body surface, often requiring hospitalization due to risks such as fluid loss, electrolyte imbalance, and sepsis (Gonzlez-Rivera et al

[DOI] [PubMed] [Google Scholar] 32.Jeong I.-K., Han A., Jun J.E., Hwang Y.-C., Ahn K.J., Chung H.Y., Kang B.S., Choung S.-Y